Phase 3 Clinical Trial of CartiLife® in Korea
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chong Bum Chang, MD
Seoul National University Bundang Hospital (1)
Principal Investigator - Dong Hwi Kim, MD
Chosun University Hospital
Principal Investigator - Hyuk-Soo Han, MD
Seoul National University Hospital
Principal Investigator - Jae Doo Yoo, MD
Ewha Womans University Mokdong Hospital
Principal Investigator - Ji Hoon Bae, MD
Korea University Guro Hospital
Principal Investigator - Jong Geun Seon, MD
Chonnam National University Hospital
Principal Investigator - Joon Ho Wang, MD
Samsung Medical Center
Principal Investigator - Jungsun Lee, Ph.D
Biosolution Co., Ltd.
Study Director - Kyoung Ho Yoon, MD
Kyung Hee University Hospital
Principal Investigator - Min Jung, MD
Severance Hospital
Principal Investigator - Sang Hak Lee, MD
Kyung Hee University Hospital at Gangdong
Principal Investigator - Sang Won Moon, MD
Haeundae Paik Hospital, Inje University
Principal Investigator - Seok Jung Kim, MD
The Catholic UNIV. of Korea Uijeongbu St. Mary's Hospital
Principal Investigator - Seung Joon Rhee, MD
Pusan National University Hospital
Principal Investigator - Sung-Hwan Kim, MD
Gangnam Severance Hospital
Principal Investigator - Yong In, MD
The Catholic UNIV. of Korea Seoul St. Mary's Hospital
Principal Investigator - Yong Seuk Lee, MD
Seoul National University Bundang Hospital (2)
Principal Investigator - Young Choi, MD
Kosin University Gospel Hospital
Principal Investigator - Young-Mo Kim, MD
Chungnam National University Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Inje University Haeundae Paik Hospital
Busan, South Korea
- Kosin University Gospel Hospital
Busan, South Korea
- Chungnam National University Hospital
Daejeon, South Korea
- Chonnam National University Hwasun Hospital
Gwangju, South Korea
- Chosun University Hospital
Gwangju, South Korea
- Pusan National University Hospital
Pusan, South Korea
- Seoul National University Bundang Hospital (1)
Seongnam-si, South Korea
- Seoul National University Bundang Hospital (2)
Seongnam-si, South Korea
- Ewha Womans University Mokdong Hospital
Seoul, South Korea
- Gangnam Severance Hospital
Seoul, South Korea
- Korea University Guro Hospital
Seoul, South Korea
- Kyung Hee University Hospital
Seoul, South Korea
- Kyung Hee University Hospital at Gangdong
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Severance Hospital
Seoul, South Korea
- the Catholic Univ. of Korea Seoul St. Mary'S Hospital
Seoul, South Korea
- the Catholic Univ. of Korea Uijeongbu St. Mary'S Hospital
Uijeongbu-si, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Mar 2020
- Primary completion
- 30 Sept 2023
- Completion
- 30 Sept 2024
- Last update posted
- 17 May 2022
- Registered enrollment
- 104
- Registry id
- NCT05051332
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.